Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP) in mCRC Patients Treated With First-line Bevacizumab

NCT02511756 is registered in ClinicalTrials.gov with Patrick Veit-Haibach as lead sponsor.

NCT NCT02511756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02511756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP) in mCRC Patients Treated With First-line Bevacizumab
Lead sponsor
Patrick Veit-Haibach
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2015
Completion date
April 30, 2017
Enrollment
50 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer